Skip to main content

Instant view: Britain accepts the COVID-19 vaccine from Pfizer, which will be released next week.

(Reuters) - On Wednesday, Britain became the first country in the world to approve the COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech, and said it would be launched early next week.

IMMUNOLOGY PROFESSOR AT IMPERIAL COLLEGE LONDON, DANNY ALTMANN:

Exciting news continues to arrive, but it's very momentous. Nobody knew how the war would pan out to find productive vaccines. Now, less than 11 months after the first virus sequence characterization, we have obtained our first emergency approval for the use of a vaccine that is genuinely safe. Heroic indeed. I don't think we're supposed to get too hung up on the 'race' as the 1st approval. We will likely see a variety of licenses issued over the next few weeks, and we need them all to get out of this mess quickly.

Comments

New comments are not allowed.

Popular posts from this blog

Britain's navy in the event of a no-deal Brexit to defend fishing waters

LONDON (Reuters) - In the event that the Brexit transition phase ends on Dec. 31 without an agreement on future relations with the European Union, four Royal Navy patrol ships are on standby to defend Britain's fishing waters, the Ministry of Defence (MOD) said. The step attracted criticism from lawmakers within the Conservative Party of British Prime Minister Boris Johnson, but was brushed off by the French government. "Keep calm and carry on," said an Elysée official, using a British wartime slogan. Where no trade agreement is reached, questions are raised about potential skirmishes between British and international fishing vessels, with current transitional rules allowing EU boats access to British waters set to expire by the end of the year. "An MOD spokesman said The MOD has carried out comprehensive training and preparation to ensure that Defence is ready at the end of the Transition Phase for a variety of scenarios. The 80-meter-long navy vessels would h...
Post a Comment
Read more

The CEO of AstraZeneca plans to conduct the latest global COVID-19 vaccine trial: Bloomberg

(Reuters) - An additional global trial to test the effectiveness of its COVID-19 vaccine using a lower dose is likely to be conducted by AstraZeneca, its chief executive was quoted as saying on Thursday amid concerns about the outcome of its late-stage review. AstraZeneca could start a new study to test a lower dose of its vaccine that worked better than a full dosage, Pascal Soriot told Bloomberg News, instead of adding the trial to an existing U.S. phase. "We have to validate this now that we have discovered what looks like a better efficacy, so we need to do an additional study," he said, adding that the latest, likely global, study could be quicker because it would require less subjects as the effectiveness was already established to be high. The news comes as AstraZeneca faces concerns about its success rate that some analysts claim could impede its chances of securing rapid regulatory approval from the U.S. and EU. Several scientists have raised concerns about the r...
Post a Comment
Read more

In 'challenging point' Brexit trade negotiations, British minister says

LONDON (Reuters) - Brexit trade negotiations are in a difficult process, and only if the European Union understands that Britain is a sovereign nation will an agreement be reached, said Business Secretary Alok Sharma. "We're at a critical stage," Sky TV told Sharma. "It is fair to say that we are in a difficult phase, that there are still some difficult problems to solve." "We have always said right from the beginning of this process that only if the EU recognizes that the UK is a sovereign independent nation can an agreement be reached," Sharma said. "It is on the basis of that a deal will be done."
Post a Comment
Read more